Calloway News
 
 

Calloway Celebrates 4th Year

Calloway Labs celebrated its fourth successful year of growth this past September. Beginning in late 2003 with three employees in a one room laboratory, the company has grown to 180 people serving over 1,000 doctors and substance abuse facilities in 23 states. Its new state-of-the-art facility in Woburn, Massachusetts will accommodate growth for the next three years. “I’m delighted with how far Calloway has come in such a short time,” said Arthur Levitan, the company’s founder. “The Calloway team has truly delivered on our original vision that a customer-centric company can succeed in this competitive marketplace.”

Calloway Leads with its Drug Testing Portfolio

Calloway remains at the forefront in providing the latest in urine toxicology testing. Today the company tests for 17 drugs and 7 adulterants – with more added each year. The list includes:

17 Available Drug Tests

  • Amphetamines
  • Barbiturates
  • Benzodiazepines
  • Cocaine Metabolite
  • Propoxyphene
  • PCP
  • THC
  • Ethanol
  • Opiates
  • Methadone
  • MDMA
  • Oxycodone
  • Buprenorphine
  • Tramadol NEW!
  • Fentanyl
  • ETG
  • Meperidine COMING SOON!

7 Available Adulterant Tests

  • Aldehyde
  • Chromate
  • Creatinine
  • Nitrate
  • Oxidase
  • pH
  • Specific Gravity

Calloway’s HL7 Interface Now Available for Electronic Test Results

This summer Calloway implemented a new laboratory automation system (LIMS). In addition to better reporting capabilities, Calloway can now interface with the medical records systems at physician offices, clinics and hospitals. Using the HL7 interface standard, drug test results from Calloway can be electronically sent to other medical systems.

Calloway Adds New Confirmation Technology

Calloway recently added new technology to maintain its position as the leader in toxicology testing. The addition of cutting edge technology includes Liquid Chromatography/Mass Spectrometry equipment. This enables confirmation testing for drugs that cannot be tested using other confirmation techniques including Benzodiazepines and Buprenorphine.

Calloway Adds Enhanced Report Capabilities

Leveraging its new laboratory automation system, Calloway has created a proprietary reporting portal so that customers can view test results in a variety of convenient ways. The new reporting capability includes the following features:

  • User customizable reporting dashboard
  • Cumulative reporting by patient, doctor, facility
  • User customizable folders to accumulate patient records
  • New announcement board for important Calloway notices
  • Personal messaging feature for direct communication with Customer Service
  • Enhanced search function
  • Electronic ordering of Calloway supplies
 
             
     
Top of Page
     
 

About the company | Calloway's Services | Customized Protocols | Industry News | Resources and Library | Contact Us

© Calloway Labs. All rights reserved.